Showing results (41-50 of 611) with videos related to

Sort By:
Pageof 62
Drugs|July 2, 2003
Rate control in atrial fibrillation: choice of treatment and assessment of efficacyGiuseppe Boriani, Mauro Biffi, Igor Diemberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 17, 2008
Is atrial fibrillation with very short cycle length suitable for ablation? A case reportIgor Diemberger, James McCready, Laurence Nunn, et al.
Drug Design, Development and Therapy|August 11, 2021
Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the GapNicolina Conti, Milo Gatti, Emanuel Raschi, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 2, 2017
Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial FibrillationSimon Pecha, Susanne Ghandili, Samer Hakmi, et al.
Indian Heart Journal|March 21, 2016
New left ventricular active fixation lead: The experience of lead extractionMatteo Ziacchi, Igor Diemberger, Cristian Martignani, et al.
Drugs|November 26, 2004
Pharmacological cardioversion of atrial fibrillation: current management and treatment optionsGiuseppe Boriani, Igor Diemberger, Mauro Biffi, et al.
Journal of Cardiovascular Pharmacology|February 29, 2012
Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activityAlexander Burashnikov, Hector Barajas-Martinez, Dan Hu, et al.
Artificial Organs|February 28, 2014
Efficacy of prophylactic intra-aortic balloon pump therapy in chronic heart failure patients undergoing cardiac surgeryYalin Yildirim, Simon Pecha, Mathias Kubik, et al.
Expert Review of Medical Devices|October 15, 2025
A review on the impact of cardiac pacing on right ventricular and tricuspid valve functionAlphonsus Liew, Nadeev Wijesuriya, Sandra Howell, et al.
Pageof 62